Profil
Christopher Sweeney is Medical Director of Semafore Pharmaceuticals, Inc. and Clinical Director of the Developmental Therapeutics Program for the Division of Hematology and Oncology of the IU Medical School Cancer Center.
He was an Internal Medicine Resident of the Gundersen Lutheran Medical Center from 1994 to 1997 and a Fellow in Hematology and Oncology of the Indiana University Medical Center from 1997 to 2000.
He received an MD from the University of Adelaide in 1992.
Ehemalige bekannte Positionen von Christopher Sweeney
Unternehmen | Position | Ende |
---|---|---|
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Ausbildung von Christopher Sweeney
University of Adelaide | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |